We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Sanofi-Aventis Puts a New GC Workhorse Through its Paces: A Case Study

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Thermo Fisher Scientific has announced a customer case study on the effective adoption of upgraded gas chromatography (GC) technology into an existing workflow with improved results and minimal effort.

Dr. Dietrich Hilke, Head of Laboratory, Sanofi-Aventis, Deutschland GmbH, Frankfurt, and his team participated in the planning, testing, and evaluation of a new GC platform.

Dr. Hilke’s laboratory analyzes 500 to 700 sample batches per year in a regulated environment for quality control of excipients, drug substances, and drug products.

The team was able to directly transfer existing methods to the new GC system thus saving large amounts of time and effort.

The new system has yielded better results than existing instruments, and Dr. Hike says, “The user-exchange of the instant connect injector and detector modules is quick and functional. The low temperature of the injection head has the practical advantage of replacing a new liner without losing any time. The simple and quick adaptation from liquid to headspace sampling is a great advance and is very helpful for daily user operations. Overall, the Thermo Scientific™ TRACE™ 1310 GC is very flexible and user-friendly for a wide range of applications.”